- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | AGC Biologics Enters Gene Therapy Manufacturing Agreement with AAVantgarde | ||
| Do | Novartis to Create New Flagship Manufacturing Hub in North Carolina | ||
| Do | ProFound Therapeutics, Quotient Therapeutics Enter Collaborations with GSK | ||
| Mi | Piramal's Grangemouth, UK Facility Receives Updated MHRA GMP Certificates | ||
| Mi | Lilly to Open Lilly Gateway Labs Site in Philadelphia | ||
| Mi | Alkermes Ups Bid for Avadel to $2.37 Billion After Rival Offer | ||
| Mi | Primerdesign Launches Exsig Mag RapidBead Pro Extraction Kit | ||
| Mi | EC Approves Subcutaneous Administration of Keytruda | ||
| Mi | AGC Biologics, Repair Biotechnologies Partner to Develop & Manufacture mRNA Therapeutic | ||
| Di | Johnson & Johnson 3Q Results | ||
| Di | Agenus Taps Dr. José Iglesias as Chief Medical Affairs Officer | ||
| Di | Halozyme Therapeutics Acquires Elektrofi for $750M | ||
| Di | BioDuro Launches Peptide Business Unit | ||
| Di | Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Philadelphia | ||
| Di | Debiopharm Launches IDEAL Japan Initiative | ||
| Di | European Commission Approves Remsima IV Liquid Formulation | ||
| Mo | Solve Therapeutics Raises $120M in Latest Funding Round | ||
| Mo | Andelyn Biosciences Signs Licensing Agreement with Solid Biosciences | ||
| Mo | Merus, Halozyme Partner to Develop Subcutaneous Formulation of Petosemtamab | ||
| Mo | AdvanCell Appoints Philina Lee as CEO | ||
| Mo | Polpharma Biologics Launches Tyruko in the U.S. | ||
| Mo | Sonoma Biotherapeutics Names Stephen Dilly as CEO | ||
| 14.11. | Merck 3Q Results | ||
| 14.11. | Pfizer 3Q Results | ||
| 14.11. | Abbvie 3Q Results |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .